HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

2nd Edition of International Summit on Hematology and Blood Disorders

June 05-07, 2025

June 05 -07, 2025 | Rome, Italy
Hematology 2025

Multiple alloantibodies: The strategy for identifying antibodies and transfusion management

Ahmed Alharbi, Speaker at Hematology Conferences
King Abdulaziz Medical City, Saudi Arabia
Title : Multiple alloantibodies: The strategy for identifying antibodies and transfusion management

Abstract:

Patients with multiple alloantibodies exhibit wildly different matching patterns and reaction intensities. Thus, alloantibodies need to have their specificity and clinical importance verified. In the presence of multiple antibodies in the patient’s sample, it is necessary to study well each antibody's pattern and its phase to confirm the specificity and clinical significance of alloantibodies and suggest any clear distinct specific further pathway that can assist with identification of each antibody in confident. Generally, the blood bank centers that serve different patient categories, including hematological and post-stem cell transplants should have a clear pathway for how is the route of administration of multiple non-ABO-all antibodies and select the proper unit phenotype for blood transfusion in this case multiple antibodies were identified anti-E-, anti-s , anti-K-, and anti-P1- so the selected red blood cells should be negative to all identified antibodies . more over the availability of the resources that include the different reagent manufactures, resources in addition the availability of all enough stock of blood and blood products to give chance to switch patients to suitable blood group as alternative solution and avoiding the delay of patient care.

Biography:

Ahmad Alharbi (M.D), a graduate of Qassim University, School of Medicine, Qassim, Saudi Arabia, where he earned a Bachelor of Medicine and Surgery (MBBS) in 2010. After graduating, he completed a residency training program in internal medicine from King Abdulaziz Medical City, Riyadh, Saudi Arabia. Afterward, he completed a Fellowship program in infectious diseases from King Abdulaziz Medical City. He subspecialized in HIV (Human immunodeficiency disease) by having an HIV clinical fellowship from McMaster University, Canada). He has been practicing in the department of Infectious disease in King Abdulaziz Medical city as a consultant since 2019.

Watsapp